Has Steven Pliszka, MD received payments from drug or device companies?

Yes. Drug and device makers reported $58,767 in general payments to Steven Pliszka, MD across 59 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Pliszka, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Pliszka, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Pliszka, MD

Child & Adolescent Psychiatry · San Antonio, TXNPI 1245249069

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $41,160 of the $58,767 with a category attached, or 70.0%. Ironshore Pharmaceuticals Inc. accounts for 82.6% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $33,906 and has fallen 99.8% since, to $56 in 2025. Among child & adolescent psychiatry clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$58,767in general payments, 2019–2025

Across 59 payments — averaging $996.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Ironshore Pharmaceuticals Inc.$49K
Adlon Therapeutics L.p.$9K
Supernus Pharmaceuticals, Inc.$957

$138,493in research payments, 2019–2025

Across 34 payments — averaging $4073.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Otsuka Pharmaceutical Development & Commercialization, Inc.$124K
Shire North American Group Inc$13K
Neos Therapeutics, LP$1K

What the payments were for

Consulting fees$14,09624%
Speaking & faculty fees$41,16070%
Food & beverage$3,5116%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Ironshore Pharmaceuticals Inc.	52	$48,514
Adlon Therapeutics L.p.	2	$9,296
Supernus Pharmaceuticals, Inc.	5	$957

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Jornay PM 20mg capsules (Bottle of 100)$33,729
JORNAY PM$14,520
ADHANSIA XR$9,296
QELBREE$845

How this compares

$58,767 in reported general payments places this provider in the 95th percentile of 301 child & adolescent psychiatry providers in Texas.

See all child & adolescent psychiatry providers in Texas →

Medicare billing

Part B allowed, 2024

$17,371

Medicare patients

Services billed

176

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
AustedoDeutetrabenazine	12	$62,927
Aripiprazole	145	$9,323
Quetiapine Fumarate	188	$5,601
Divalproex Sodium ErDivalproex Sodium	62	$4,207
Oxcarbazepine	33	$3,132
Memantine Hcl ErMemantine Hcl	12	$1,708
Naltrexone Hcl	12	$1,515
Sertraline Hcl	121	$1,358
Bupropion XlBupropion Hcl	36	$1,349
Methylphenidate ErMethylphenidate Hcl	12	$1,302
Divalproex Sodium	29	$1,282
Risperidone	73	$1,273
Olanzapine	45	$1,010
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	11	$925
Citalopram HbrCitalopram Hydrobromide	64	$802

Paid to pharmacies, not to this prescriber.

Other child & adolescent psychiatry in San Antonio

Mary Garcia HolguinSan Antonio$24K
Maria DominguezSan Antonio$7K
Amber MansoorSan Antonio$6K
Andrew MartinSan Antonio$6K
Thomas DemoorSan Antonio$5K
Vanessa VelaSan Antonio$3K
Marguerite HoganSan Antonio$3K
Grace Salinas GarciaSan Antonio$2K
Hector SamaniegoSan Antonio$2K
Alain KaticBellaire$106K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →